Myelination and the trophic support of long axons

Nature Reviews Neuroscience

Volumn 11, Issue 4, 2010, Pages 275-283

  Nave, Klaus Armin ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

CELL INTERACTION; GLIA CELL; GLYCOLYSIS; HUMAN; MOTOR PERFORMANCE; MYELIN DEFICIENCY; MYELIN SHEATH; MYELINATION; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER DEGENERATION; NERVE FIBER MEMBRANE; NERVE FIBER TRANSPORT; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME;

ANIMALS; AXONAL TRANSPORT; AXONS; DEMYELINATING DISEASES; HUMANS; MODELS, NEUROLOGICAL; MYELIN SHEATH; NERVE DEGENERATION; NEUROGLIA;

EID: 77949873025     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn2797     Document Type: Review

References (139)

1. Herculano-Houzel, S., Mota, B. & Lent, R. Cellular scaling rules for rodent brains. Proc. Natl Acad. Sci. USA 103, 12138-12143 (2006).
2. Griffiths, I. et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280, 1610-1613 (1998).
3. Lappe-Siefke, C. et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nature Genet. 33, 366-374 (2003).
4. Kassmann, C. M. et al. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nature Genet. 39, 969-976 (2007).
5. Yin, X. et al. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci. 18, 1953-1962 (1998).
6. Zalc, B. & Colman, D. R. Origins of vertebrate success. Science 288, 271-272 (2000).
7. Hildebrand, C., Remahl, S., Persson, H. & Bjartmar, C. Myelinated nerve fibres in the CNS. Prog. Neurobiol. 40, 319-384 (1993).
8. Hildebrand, C., Bowe, C. M. & Remahl, I. N. Myelination and myelin sheath remodelling in normal and pathological PNS nerve fibres. Prog. Neurobiol. 43, 85-141 (1994).
9. Perkins, G. A. et al. Electron tomographic analysis of cytoskeletal cross-bridges in the paranodal region of the node of Ranvier in peripheral nerves. J. Struct. Biol. 161, 469-480 (2008).
10. Rosenbluth, J. Multiple functions of the paranodal junction of myelinated nerve fibers. J. Neurosci. Res. 87, 3250-3258 (2009).
11. Salzer, J. L., Brophy, P. J. & Peles, E. Molecular domains of myelinated axons in the peripheral nervous system. Glia 56, 1532-1540 (2008).
12. Fields, R. D. Oligodendrocytes changing the rules: action potentials in glia and oligodendrocytes controlling action potentials. Neuroscientist 14, 540-543 (2008).
13. Simons, M. & Trotter, J. Wrapping it up: the cell biology of myelination. Curr. Opin. Neurobiol. 17, 533-540 (2007).
14. Trapp, B. D. & Nave, K. A. Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 31, 247-269 (2008).
15. Schiffmann, R. & van der Knaap, M. S. The latest on leukodystrophies. Curr. Opin. Neurol. 17, 187-192 (2004).
16. Suter, U. & Scherer, S. S. Disease mechanisms in inherited neuropathies. Nature Rev. Neurosci. 4, 714-726 (2003).
17. Fields, R. D. White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 31, 361-370 (2008).
18. Ferguson, B., Matyszak, M. K., Esiri, M. M. & Perry, V. H. Axonal damage in acute multiple sclerosis lesions. Brain 120, 393-399 (1997).
19. Trapp, B. D. et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278-285 (1998).
20. Garbern, J. Y. et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125, 551-561 (2002).
21. Nave, K. A., Sereda, M. W. & Ehrenreich, H. Mechanisms of disease: inherited demyelinating neuropathies \ from basic to clinical research. Nature Clin. Pract. Neurol. 3, 453-464 (2007).
22. Scherer, S. S. & Wrabetz, L. Molecular mechanisms of inherited demyelinating neuropathies. Glia 56, 1578-1589 (2008).
23. Pareyson, D., Scaioli, V. & Laura, M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med. 8, 3-22 (2006).
24. Griffin, J. W. & Watson, D. F. Axonal transport in neurological disease. Ann. Neurol. 23, 3-13 (1988).
25. Zipp, F. & Aktas, O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 29, 518-527 (2006).
26. Neumann, H., Medana, I. M., Bauer, J. & Lassmann, H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25, 313-319 (2002).
27. Smith, K. J. & Lassmann, H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1, 232-241 (2002).
28. Trapp, B. D. & Stys, P. K. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 8, 280-291 (2009).
29. Waxman, S. G. Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosis. Trends Mol. Med. 12, 192-195 (2006).
30. 2+ exchanger. Proc. Natl Acad. Sci. USA 101, 8168-8173 (2004).
31. 2+ exchanger. J. Neurosci. 12, 430-439 (1992)
32. Stys, P. K. Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J. Cereb. Blood Flow Metab. 18, 2-25 (1998).
33. Salter, M. G. & Fern, R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438, 1167-1171 (2005).
34. Micu, I. et al. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 439, 988-992 (2006).
35. Ouardouz, M. et al. Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann. Neurol. 65, 151-159 (2009).
36. Ouardouz, M. et al. Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann. Neurol. 65, 160-166 (2009).
37. Newman, T. A. et al. T-cell-and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases. Brain 124, 2203-2214 (2001).
38. De Waegh, S. M., Lee, V. M. & Brady, S. T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68, 451-463 (1992).
39. Sanchez, I., Hassinger, L., Paskevich, P. A., Shine, H. D. & Nixon, R. A. Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation. J. Neurosci. 16, 5095-5105 (1996).
40. Inoue, Y., Nakamura, R., Mikoshiba, K. & Tsukada, Y. Fine structure of the central myelin sheath in the myelin deficient mutant Shiverer mouse, with special reference to the pattern of myelin formation by oligodendroglia. Brain Res. 219, 85-94 (1981).
41. Shine, H. D., Readhead, C., Popko, B., Hood, L. & Sidman, R. L. Morphometric analysis of normal, mutant, and transgenic CNS: correlation of myelin basic protein expression to myelinogenesis. J. Neurochem. 58, 342-349 (1992).
42. Rosenbluth, J. Central myelin in the mouse mutant shiverer. J. Comp. Neurol. 194, 639-648 (1980).
43. Andrews, H. et al. Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse. J. Neurosci. Res. 83, 1533-1539 (2006).
44. Brady, S. T. et al. Formation of compact myelin is required for maturation of the axonal cytoskeleton. J. Neurosci. 19, 7278-7288 (1999).
45. Saher, G. et al. High cholesterol level is essential for myelin membrane growth. Nature Neurosci. 8, 468-475 (2005).
46. Saher, G. et al. Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction. J. Neurosci. 29, 6094-6104 (2009).
47. Klugmann, M. et al. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18, 59-70 (1997).
48. Edgar, J. M. et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J. Cell Biol. 166, 121-131 (2004).
49. Edgar, J. M. et al. Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. Glia 57, 1815-1824 (2009).
50. Rosenbluth, J., Nave, K. A., Mierzwa, A. & Schiff, R. Subtle myelin defects in PLP-null mice. Glia 54, 172-182 (2006).
51. Yin, X. et al. Evolution of a neuroprotective function of central nervous system myelin. J. Cell Biol. 172, 469-478 (2006).
52. Ferreirinha, F. et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J. Clin. Invest. 11 3, 231-242 (2004).
53. Tarrade, A. et al. A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum. Mol. Genet. 15, 3544-3558 (2006).
54. Rasband, M. N. et al. CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia 50, 86-90 (2005).
55. Garcia-Fresco, G. P. et al. Disruption of axo-glial junctions causes cytoskeletal disorganization and degeneration of Purkinje neuron axons. Proc. Natl Acad. Sci. USA 103, 5137-5142 (2006).
56. Higuchi, M. et al. Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies. J. Neurosci. 25, 9434-9443 (2005).
57. Yazawa, I. et al. Mouse model of multiple system atrophy α-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45, 847-859 (2005).
58. Zoller, I. et al. Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration. J. Neurosci. 28, 9741-9754 (2008).
59. Montag, D. et al. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13, 229-246 (1994).
60. Li, C. et al. Myelination in the absence of myelin-associated glycoprotein. Nature 369, 747-750 (1994).
61. Nguyen, T. et al. Axonal protective effects of the myelin-associated glycoprotein. J. Neurosci. 29, 630-637 (2009).
62. Zhou, L. & Griffin, J. W. Demyelinating neuropathies. Curr. Opin. Neurol. 16, 307-313 (2003).
63. Marrosu, M. G. et al. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 50, 1397-1401 (1998).
64. Laura, M. et al. Rapid progression of late onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain. J. Neurol. Neurosurg. Psychiatry 78, 1263-1266 (2007).
65. Sousa, A. D. & Bhat, M. A. Cytoskeletal transition at the paranodes: the Achilles' heel of myelinated axons. Neuron Glia Biol. 3, 169-178 (2007).
66. Kirkpatrick, L. L., Witt, A. S., Payne, H. R., Shine, H. D. & Brady, S. T. Changes in microtubule stability and density in myelin-deficient shiverer mouse CNS axons. J. Neurosci. 21, 2288-2297 (2001).
67. Uschkureit, T., Sporkel, O., Stracke, J., Bussow, H. & Stoffel, W. Early onset of axonal degeneration in double (plp-/-mag-/-) and hypomyelinosis in triple (plp-/-mbp-/-mag-/-) mutant mice. J. Neurosci. 20, 5225-5233 (2000).
68. Du, Y. & Dreyfus, C. F. Oligodendrocytes as providers of growth factors. J. Neurosci. Res. 68, 647-654 (2002).
69. Dai, X. et al. The trophic role of oligodendrocytes in the basal forebrain. J. Neurosci. 23, 5846-5853 (2003).
70. Wilkins, A., Majed, H., Layfield, R., Compston, A. & Chandran, S. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J. Neurosci. 23, 4967-4974 (2003).
71. McGrail, K. M., Phillips, J. M. & Sweadner, K. J. Immunofluorescent localization of three Na, K-ATPase isozymes in the rat central nervous system: both neurons and glia can express more than one Na, K-ATPase. J. Neurosci. 11, 381-391 (1991).
72. + ATPase in chronic multiple sclerosis lesions. Ann. Neurol. 63, 428-435 (2008).
73. Tachikawa, M. et al. Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur. J. Neurosci. 20, 144-160 (2004).
74. Brady, S. T. & Lasek, R. J. Nerve-specific enolase and creatine phosphokinase in axonal transport: soluble proteins and the axoplasmic matrix. Cell 23, 515-523 (1981).
75. Oblinger, M. M., Foe, L. G., Kwiatkowska, D. & Kemp, R. G. Phosphofructokinase in the rat nervous system: regional differences in activity and characteristics of axonal transport. J. Neurosci. Res. 21, 25-34 (1988).
76. Yuan, A., Mills, R. G., Bamburg, J. R. & Bray, J. J. Cotransport of glyceraldehyde-3-phosphate dehydrogenase and actin in axons of chicken motoneurons. Cell. Mol. Neurobiol. 19, 733-744 (1999).
77. Galbraith, D. A. & Watts, D. C. Changes in some cytoplasmic enzymes from red cells fractionated into age groups by centrifugation in Ficoll/Triosil gradients. Comparison of normal humans and patients with Duchenne muscular dystrophy. Biochem. J. 191, 63-70 (1980).
78. Kuehl, L. & Sumsion, E. N. Turnover of several glycolytic enzymes in rat liver. J. Biol. Chem. 245, 6616-6623 (1970).
79. Medori, R., Autilio-Gambetti, L., Monaco, S. & Gambetti, P. Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area. Proc. Natl Acad. Sci. USA 82, 7716-7720 (1985).
80. Spencer, P. S., Sabri, M. I., Schaumburg, H. H. & Moore, C. L. Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies? Ann. Neurol. 5, 501-507 (1979).
81. Morland, C., Henjum, S., Iversen, E. G., Skrede, K. K. & Hassel, B. Evidence for a higher glycolytic than oxidative metabolic activity in white matter of rat brain. Neurochem. Int. 50, 703-709 (2007).
82. Brinster, R. L. Lactate dehydrogenase activity in the preimplanted mouse embryo. Biochim. Biophys. Acta 11 0, 439-441 (1965).
83. Selak, I., Skaper, S. D. & Varon, S. Pyruvate participation in the low molecular weight trophic activity for central nervous system neurons in glia-conditioned media. J. Neurosci. 5, 23-28 (1985).
84. Suh, S. W., Aoyama, K., Matsumori, Y., Liu, J. & Swanson, R. A. Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. Diabetes 54, 1452-1458 (2005).
85. Hertz, L., Peng, L. & Dienel, G. A. Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J. Cereb. Blood Flow Metab. 27, 219-249 (2007).
86. Dringen, R., Wiesinger, H. & Hamprecht, B. Uptake of L-lactate by cultured rat brain neurons. Neurosci. Lett. 163, 5-7 (1993).
87. Pellerin, L. & Magistretti, P. J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl Acad. Sci. USA 91, 10625-10629 (1994).
88. Chih, C. P. & Roberts, E. L. Jr. Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis. J. Cereb. Blood Flow Metab. 23, 1263-1281 (2003).
89. Allen, N. J., Karadottir, R. & Attwell, D. A preferential role for glycolysis in preventing the anoxic depolarization of rat hippocampal area CA1 pyramidal cells. J. Neurosci. 25, 848-859 (2005).
90. Magistretti, P. J. Neuron-glia metabolic coupling and plasticity. J. Exp. Biol. 209, 2304-2311 (2006).
91. Wender, R. et al. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J. Neurosci. 20, 6804-6810 (2000).
92. Brown, A. M., Wender, R. & Ransom, B. R. Metabolic substrates other than glucose support axon function in central white matter. J. Neurosci. Res. 66, 839-843 (2001).
93. Baltan, S. Surviving anoxia: a tale of two white matter tracts. Crit. Rev. Neurobiol. 18, 95-103 (2006).
94. Butt, A. M., Colquhoun, K. & Berry, M. Confocal imaging of glial cells in the intact rat optic nerve. Glia 10, 315-322 (1994).
95. Orthmann-Murphy, J. L., Freidin, M., Fischer, E., Scherer, S. S. & Abrams, C. K. Tw o distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins. J. Neurosci. 27, 13949-13957 (2007).
96. Robinson, S. R., Hampson, E. C., Munro, M. N. & Vaney, D. I. Unidirectional coupling of gap junctions between neuroglia. Science 262, 1072-1074 (1993).
97. Rash, J. E. et al. Grid-mapped freeze-fracture analysis of gap junctions in gray and white matter of adult rat central nervous system, with evidence for a "panglial syncytium" that is not coupled to neurons. J. Comp. Neurol. 388, 265-292 (1997).
98. Uhlenberg, B. et al. Mutations in the gene encoding gap junction protein α12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am. J. Hum. Genet. 75, 251-260 (2004).
99. Orthmann-Murphy, J. L. et al. Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain 132, 426-438 (2009).
100. Odermatt, B. et al. Connexin 47 (Cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of Cx47 and display vacuolized myelin in the CNS. J. Neurosci. 23, 4549-4559 (2003).
101. Menichella, D. M., Goodenough, D. A., Sirkowski, E., Scherer, S. S. & Paul, D. L. Connexins are critical for normal myelination in the central nervous system. J. Neurosci. 23, 5963-5973 (2003).
102. Menichella, D. M. et al. Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity. J. Neurosci. 26, 10984-10991 (2006).
103. Lutz, S. E. et al. Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J. Neurosci. 29, 7743-7752 (2009).
104. Black, J. A., Foster, R. E. & Waxman, S. G. Rat optic nerve: freeze-fracture studies during development of myelinated axons. Brain Res. 250, 1-20 (1982).
105. Moffett, J. R., Ross, B., Arun, P., Madhavarao, C. N. & Namboodiri, A. M. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog. Neurobiol. 81, 89-131 (2007).
106. Jalil, M. A. et al. Reduced N-acetylaspartate levels in mice lacking aralar, a brain-and muscle-type mitochondrial aspartate-glutamate carrier. J. Biol. Chem. 280, 31333-31339 (2005).
107. Tekkok, S. B., Brown, A. M., Westenbroek, R., Pellerin, L. & Ransom, B. R. Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J. Neurosci. Res. 81, 644-652 (2005).
108. Einheber, S., Bhat, M. A. & Salzer, J. L. Disrupted axo-glial junctions result in accumulation of abnormal mitochondria at nodes of ranvier. Neuron Glia Biol. 2, 165-174 (2006).
109. Roussarie, J. P., Ruffie, C. & Brahic, M. The role of myelin in Theiler's virus persistence in the central nervous system. PLoS Pathog. 3, e23 (2007).
110. Ransom, B. R., Butt, A. M. & Black, J. A. Ultrastructural identification of HRP-injected oligodendrocytes in the intact rat optic nerve. Glia 4, 37-45 (1991).
111. Mastro, A. M. & Keith, A. D. Diffusion in the aqueous compartment. J. Cell Biol. 99, 180s-187s (1984).
112. Butt, A. M. & Ransom, B. R. Visualization of oligodendrocytes and astrocytes in the intact rat optic nerve by intracellular injection of lucifer yellow and horseradish peroxidase. Glia 2, 470-475 (1989).
113. Hochachka, P. W. Intracellular convection, homeostasis and metabolic regulation. J. Exp. Biol. 206, 2001-2009 (2003).
114. Butt, A. M. & Jenkins, H. G. Morphological changes in oligodendrocytes in the intact mouse optic nerve following intravitreal injection of tumour necrosis factor. J. Neuroimmunol. 51, 27-33 (1994).
115. Werner, H. B. et al. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J. Neurosci. 27, 7717-7730 (2007).
116. Li, W. et al. Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating a-tubulin. J. Neurosci. 27, 2606-2616 (2007).
117. Southwood, C. M., Peppi, M., Dryden, S., Tainsky, M. A. & Gow, A. Microtubule deacetylases, SirT2 and HDAC6, in the nervous system. Neurochem. Res. 32, 187-195 (2007).
118. +-dependent tubulin deacetylase. Mol. Cell 11, 437-444 (2003).
119. Bifulco, M., Laezza, C., Stingo, S. & Wolff, J. 2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin. Proc. Natl Acad. Sci. USA 99, 1807-1812 (2002).
120. Lee, J., Gravel, M., Zhang, R., Thibault, P. & Braun, P. E. Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J. Cell Biol. 170, 661-673 (2005).
121. Takenaka, T. et al. Fatty acids as an energy source for the operation of axoplasmic transport. Brain Res. 972, 38-43 (2003).
122. Kassmann, C. M. & Nave, K. A. Oligodendroglial impact on axonal function and survival-a hypothesis. Curr. Opin. Neurol. 21, 235-241 (2008).
123. Lasek, R. J., Gainer, H. & Przybylski, R. J. Transfer of newly synthesized proteins from Schwann cells to the squid giant axon. Proc. Natl Acad. Sci. USA 71, 1188-1192 (1974).
124. Gainer, H., Tasaki, I. & Lasek, R. J. Evidence for the glia-neuron protein transfer hypothesis from intracellular perfusion studies of squid giant axons. J. Cell Biol. 74, 524-530 (1977).
125. Lasek, R. J., Gainer, H. & Barker, J. L. Cell-to-cell transfer of glial proteins to the squid giant axon. The glia-neuron protein trnasfer hypothesis. J. Cell Biol. 74, 501-523 (1977).
126. Duncan, A., Ibrahim, M., Berry, M. & Butt, A. M. Transfer of horseradish peroxidase from oligodendrocyte to axon in the myelinating neonatal rat optic nerve: artefact or transcellular exchange? Glia 17, 349-355 (1996).
127. Court, F. A., Hendriks, W. T., Macgillavry, H. D., Alvarez, J. & van Minnen, J. Schwann cell to axon transfer of ribosomes: toward a novel understanding of the role of glia in the nervous system. J. Neurosci. 28, 11024-11029 (2008).
128. Hildebrand, C. & Waxman, S. G. Postnatal differentiation of rat optic nerve fibers: electron microscopic observations on the development of nodes of Ranvier and axoglial relations. J. Comp. Neurol. 224, 25-37 (1984).
129. Edgar, J. M. et al. Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease. EMBO Mol. Med. 2, 42-50 (2010).
130. Peters, A., Sethares, C. & Killiany, R. J. Effects of age on the thickness of myelin sheaths in monkey primary visual cortex. J. Comp. Neurol. 435, 241-248 (2001).
131. McQuarrie, I. G., Brady, S. T. & Lasek, R. J. Retardation in the slow axonal transport of cytoskeletal elements during maturation and aging. Neurobiol. Aging 10, 359-365 (1989).
132. Verdu, E., Ceballos, D., Vilches, J. J. & Navarro, X. Influence of aging on peripheral nerve function and regeneration. J. Peripher. Nerv. Syst. 5, 191-208 (2000).
133. Stokin, G. B. & Goldstein, L. S. Axonal transport and Alzheimer's disease. Annu. Rev. Biochem. 75, 607-627 (2006).
134. Szebenyi, G. et al. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40, 41-52 (2003).
135. Williamson, T. L. & Cleveland, D. W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nature Neurosci. 2, 50-56 (1999).
136. Xu, J. et al. Amyloid-b peptides are cytotoxic to oligodendrocytes. J. Neurosci. 21, RC118 (2001).
137. Schweigreiter, R., Roots, B. I., Bandtlow, C. E. & Gould, R. M. Understanding myelination through studying its evolution. Int. Rev. Neurobiol. 73, 219-273 (2006).
138. Chen, S. et al. Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nature Neurosci. 6, 1186-1193 (2003).
139. Salzer, J. L. Polarized domains of myelinated axons. Neuron 40, 297-318 (2003).